Effects of ranibizumab on human corneal endothelial cells
Conclusion Intravitreal ranibizumab injections (0.5 mg) have no harmful effects on corneal endothelial cells.
Source: Taiwan Journal of Ophthalmology - Category: Opthalmology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Study